MSAA's Public Service Announcement (PSA) Offers Information on the Importance of Disease-Modifying Therapies for MS

November 26, 2007

On November 25, 2007 MSAA began airing two public service announcements nationwide that encourage individuals with multiple sclerosis (MS) to adhere to an MS treatment plan, including one of the FDA-approved disease-modifying therapies. MSAA’s Chief  Medical Officer Dr. Jack Burks recommends that individuals with MS consult their physician, and if appropriate, begin treatment as soon as possible. Below are some helpful links on MS medications, MS, and MSAA.

MS Medications- A comprehensive listing of MS medications
About MS- An easy-to-use guide on the basics of MS
MSi Educational Video - View A Closer Look at the Importance of MS Treatment Adherence
Patient Assistance Information- Information on prescription drug assistance
MSAA Helpline- MSAA’s toll-free Helpline  (800) 532-7667
MSAA Publications- All of MSAA’s publications are available in HTML or PDF
About MSAA- Information on MSAA

Learn more about the FDA-approved treatments for MS in MSAA's brochure "Taking Steps to Feel Your Best"

For more information, please contact Amanda Bednar at (800) 532-7667, extension 122 or via email at abednar@msassociation.org.